NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 9, 2026 $4.04 +4.75% $3.46 X 83.14% 0
Jan 9, 2026 $3.97 +2.97% $3.46 X 85.13% 0
Jan 9, 2026 Bullish $3.46 X 0
Jan 8, 2026 $4.22 +4.51% $3.86 X 90.61% 0
Jan 8, 2026 $3.93 -2.82% $3.86 V 98.29% 1
Jan 8, 2026 Bullish $3.86 X 0
Jan 7, 2026 $3.92 -4.40% $4.04 V 97.02% 1
Jan 7, 2026 $3.99 -2.75% $4.04 V 98.70% 2
Jan 7, 2026 $5.96 +45.37% $4.04 X 52.48% 0
Dec 29, 2025 $2.79 -2.77% $3.35 X 83.30% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE